• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form 6-K/A filed by Ambev S.A.

    11/3/25 4:25:26 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples
    Get the next $ABEV alert in real time by email
    6-K/A 1 abev20251103_6ka.htm 6-K/A

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     


     

    FORM 6-K/A

     

    Report of Foreign Private Issuer
    Pursuant to Rule 13a-16 or 15d-16 of the

    Securities Exchange Act of 1934

     

    For the month of November, 2025

    Commission File Number 1565025

     


     

    AMBEV S.A.

    (Exact name of registrant as specified in its charter)

     

    AMBEV S.A.

    (Translation of Registrant's name into English)

     

    Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
    04530-000 São Paulo, SP
    Federative Republic of Brazil

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 


    Form 20-F ___X___ Form 40-F _______

     Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

    Yes _______ No ___X____

     
     

    Earnings Call 3Q25 This presentation was prepared by Ambev S.A. (“Ambev” or “Company”) for the exclusive use in the earnings conference call of the third quarter of 2025 (3Q25). This presentation should not be considered as a complete document and should be analyzed together with the Company’s quarterly information form (ITR/6-K) for the third quarter and the respective press release, both available on the U.S. Securities and Exchange Commission –SEC and the CVM websites. This presentation was prepared for informational purposes only and should not be considered as a solicitation or offer to buy or sell any securities of the Company, or as advice or recommendation of any nature. This presentation is not intended to be comprehensive, or to contain all the information that Ambev’s shareholders might need. No decisions on investment, disposal or any other financial decisions or actions shall be made solely on the basis ofthe information contained herein. This presentation segregates the impact of organic changes from those arising from changes in scope or currency translation. Scope changes represent the impact of acquisitions and divestitures, the start up or termination of activities or the transfer of activities between segments, curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does not consider as part of the underlying performance of the business. Organic growth and normalized numbers are presented applying constant year-over-year exchange rates to exclude the impact of the movement of foreign exchange rates. Unless stated, percentage changes in this press release are both organic and normalized in nature. Whenever used in this document, the term “normalized” refers to performance measures EBITDA and Operating Profit before exceptional items and share of results of joint ventures and to performance measures Profit and EPS before exceptional items adjustments. Exceptional items are either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the Company due to their size or nature. Normalized measures are additional measures used by management and should not replace the measures determined in accordance with IFRS as indicators of the Company’s performance. Comparisons, unless otherwise stated, refer to the third quarter of 2024 (3Q24). Values in this release may not add up due to rounding. 3Q25 Operating Performance highlights 3Q25 Delivery +8% EPS growth EBITDA growth with margin expansion Net revenue grew with resilient NR/hl up 7% Strong brand health across key markets 2025 Year-to-date perspective +7% EPS growth Cash COGS/hl grew below NR/hl EBITDA growth with margin expansion Topline growth with resilient NR/hl +Share buyback program of R$2.5 billion Growth strategy Growth strategy Lead the beer category Growth strategy Shape new avenues of growth Balanced choices ahead of total volume Core brands resilient with higher industry sensitivity Premium & Super Premium volumes up more than 9% Growth strategy Growth strategy bees Ze delivery • ZéDelivery GMV +7% • +9% AOV • BEESMarketplace strong momentum • BRL 8.0 billion annualized GMV Digital ecosystem powering insights and growth More assertive and data-driven decisions Elasticity insights by brand, pack and customer Improved distribution and production efficiency Growth strategy Growth strategy Cost discipline continues to be essential Efficiency efforts offset expected cost pressure Resources freed up to invest in our business CAC¹ +8.5% +270 bps 18% EBITDA contribution LAS¹ +4.6% -100 bps 14% EBITDA contribution CANADA¹ +2.0% +70 bps 12% EBITDA contribution BRAZIL BEER¹ +0.1% +80 bps 48% EBITDA contribution BRAZIL NAB¹ +6.1% +150 bps 8% EBITDA contribution Disciplined execution delivering results EBITDA EBITDA Mg Note: ¹3Q25 EBITDA & percentage contribution • Industry softness continued • Situational and structural factors • Category equity improved BU Brazil Beer CATEGORY INSIGHTS situational • Consumer purchasing power remained under pressure 2 1• Weather: colder-than-normal winter BU Brazil Beer Fewer occasions, particularly in the on-trade structural 1• Easy-to-drink beers 2• Sweeter beverages 3• Balanced lifestyle BU Brazil Beer Potential trends that can turn into structural drivers • Volume decline 100% explained by industry • Improved brand equity • Gained market share across all relevant segments • Core down low-teens³ & price relativity improved • Premium & Super Premium highest share levels since 2015² • Balanced choices maintainedmomentum Note: ¹Excluding non-Ambev marketplace products ²According to our estimates ³From 10.1% to 13.3% BU Brazil Beer Volume -7.7% | NR/hl¹ +5.7% Volume -8.6% | NR/hl +10.0% BU Brazil NAB • CSD industry decelerated • Market share stable to slightly down¹ • NR/hl above inflation • No-sugar portfolio up double digits² Note: ¹ According to our estimates ² From 10.0% to 19.9% BU LAS ARGENTINA Volume -0.8% | NR/hl¹+10.0% • Challenging consumption environment • Beer volumes down mid-single digits² • Brand equity remained stable Note: ¹Excluding non-Ambev marketplace products ²From 3.4% to 6.6% Dominican Republic BU CAC Volume +1.3% | NR/hl¹+1.4% • Operating environment improved sequentially • Beer share of throat increased2 • Healthier price relativity across categories • Presidente strengthened equity and reinforced leadership Note: ¹Excluding non-Ambev marketplace products ²According to our estimates Bu canada Volume -2.0% | NR/hl¹+2.0% • Beer industry declined mid-single digits³ • Outperformed the industry in beer and beyond2 • Ontario continued to grow • Michelob Ultra, Busch and Corona among top 5 volume share gainers2 Note: ¹Excluding non-Ambev marketplace products ²According to our estimates ³From 3.4% to 6.6% 3Q25 Financial Performance Investing in our business Free up resources for our business and brands Disciplined cost management Focused on maximizing return on investments EBITDA margin expansion in most of our BUs NORMALIZED Net income 3q 2025 Normalized net income q3 2024 Normalized ebitda Depreciation and amortization Net finance results Share of result of associates Income Tax expense Normalized net income q3 2025 +7% 3.58 0.00 0.13 0.58 3.84 -0.04 -0.40 (BRL billion) NORMALIZED Net income 3q 2025 Normalized net income q3 2024 Normalized ebitda Depreciation and amortization Net finance results Share of result of associates Income Tax expense Normalized net income q3 2025 3.58 0.00 0.13 -0.40 0.58 3.84 -0.04 • FX carry costs in Brazil • FX cost of sourcing in Bolivia (BRL billion) NORMALIZED Net income 3q 2025 Normalized net income q3 2024 Normalized ebitda Depreciation and amortization Net finance results Share of result of associates Income Tax expense Normalized net income q3 2025 3.58 0.00 0.13 -0.40 0.58 3.84 -0.04 • ETR: 6.7% compared to 23.6% in 3Q24 (BRL billion) NORMALIZED Net income 3q 2025 Normalized net income q3 2024 Normalized ebitda Depreciation and amortization Net finance results Share of result of associates Income Tax expense Normalized net income q3 2025 3.58 0.00 0.13 -0.40 0.58 3.84 -0.04 1. Tax amnesty partial reduction 2. Fiscal incentives 3. Barbados divestment (BRL billion) 3q 2025 cashflow Cash & cash Equivalents JUN’25 operating investing financing Exchange rates fluctuations Cash & cash Equivalents sep’25 16.4 6.9 -1.2 -0.6 18.3 (BRL billion) -3.2 Committed to returning cash to shareholders R$ 6 billion in dividends announced year-to-date Share buyback program of R$2.5 billion approved 2026 FIFA World Cup connecting passions Well positioned to close the year Thank you very much Q&A

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     
     

     

     

     

     
     

    SIGNATURE



    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

    Date: November 3, 2025

         
      AMBEV S.A.
         
      By:  /s/ Guilherme Fleury de Figueiredo Ferraz Parolari
     

    Guilherme Fleury de Figueiredo Ferraz Parolari

    Chief Financial and Investor Relations Officer


    Get the next $ABEV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABEV

    DatePrice TargetRatingAnalyst
    11/26/2025Outperform → Mkt Perform
    Bernstein
    8/1/2025Buy → Hold
    HSBC Securities
    4/22/2025Buy → Neutral
    UBS
    4/7/2025Equal-Weight → Underweight
    Morgan Stanley
    1/17/2025Buy → Neutral
    BofA Securities
    3/4/2024$3.50 → $3.00Overweight → Equal Weight
    Barclays
    3/1/2024Overweight → Neutral
    JP Morgan
    12/8/2023Underweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ABEV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AmBev downgraded by Bernstein

    Bernstein downgraded AmBev from Outperform to Mkt Perform

    11/26/25 8:31:27 AM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    AmBev downgraded by HSBC Securities

    HSBC Securities downgraded AmBev from Buy to Hold

    8/1/25 8:25:35 AM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    AmBev downgraded by UBS

    UBS downgraded AmBev from Buy to Neutral

    4/22/25 7:20:21 AM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    $ABEV
    SEC Filings

    View All

    SEC Form 6-K filed by Ambev S.A.

    6-K - AMBEV S.A. (0001565025) (Filer)

    11/10/25 4:03:24 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 6-K filed by Ambev S.A.

    6-K - AMBEV S.A. (0001565025) (Filer)

    11/10/25 4:00:54 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    Amendment: SEC Form 6-K/A filed by Ambev S.A.

    6-K/A - AMBEV S.A. (0001565025) (Filer)

    11/3/25 4:25:26 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    $ABEV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AMBEV'S 2024 ANNUAL REPORT ON FORM 20-F AVAILABLE ON OUR WEBSITE

    SÃO PAULO, March 12, 2025 /PRNewswire/ -- Ambev S.A. ([B3: ABEV3, NYSE:ABEV) announces that the Company's annual report on Form 20-F for the year ended December 31, 2024 was filed with the U.S. Securities and Exchange Commission - SEC (www.sec.gov) on March 12, 2025 and is available on the Company's website (ri.ambev.com.br) and also on the Company's page on SEC's database (www.sec.gov/edgar/). ADR holders may receive a hard copy of the Company's complete audited financial statements contained in the Form 20-F free of charge, upon request. To access the full document, please access the following links: click here. Ambev S.A. Investor Relations DepartmentContact e-mail: [email protected]

    3/12/25 7:22:00 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    AMBEV'S 2023 ANNUAL REPORT ON FORM 20-F AVAILABLE ON OUR WEBSITE

    SÃO PAULO, March 11, 2024 /PRNewswire/ -- Ambev S.A. ([B3: ABEV3, NYSE:ABEV) announces that the Company's annual report on Form 20-F for the year ended December 31, 2023 was filed with the U.S. Securities and Exchange Commission - SEC ("SEC") on March 11, 2024 and is available on the Company's website (ri.ambev.com.br) and also on the SEC (www.sec.gov/edgar/). ADR holders may receive a hard copy of the Company's complete audited financial statements contained in the Form 20-F free of charge, upon request. To access the full document, please access the following links: click here. Ambev S.A. Investor Relations DepartmentContact e-mail: [email protected] View original content:https://www

    3/11/24 6:57:00 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    AMBEV'S 2022 ANNUAL REPORT ON FORM 20-F AVAILABLE ON OUR WEBSITE

    SÃO PAULO, March 17, 2023 /PRNewswire/ -- Ambev S.A. ([B3: ABEV3, NYSE:ABEV) announces that the Company's annual report on Form 20-F for the year ended December 31, 2022 was filed with the U.S. Securities and Exchange Commission - SEC (www.sec.gov) on March 17, 2023 and is available on the Company's website (ri.ambev.com.br) and also on the Company's page on SEC's database (www.sec.gov/edgar/). ADR holders may receive a hard copy of the Company's complete audited financial statements contained in the Form 20-F free of charge, upon request. To access the full document, please access the following links: click here. CONTACT: Ambev S.A.Investor Relations DepartmentContact e-mail: [email protected]

    3/17/23 5:48:00 PM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples